Novo Nordisk A/S Common Stock (NVO)

Income Before Tax

kr 26.88B

Quarterly · Period ending: · DKK

NVO logo

NVO Income Before Tax

Latest reportedkr 26.88B DKK
NVO Quarterly Pre-Tax Income · DKK (kr 0.00 → kr 26.88B)
High-resolution chart · PNG

NVO income before tax history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Income Before Tax — Quarterly (DKK)
Period endingIncome Before Tax (DKK)
26,875,000,000
62,172,000,000
34,185,000,000
25,517,000,000
33,805,000,000
37,033,000,000
35,557,000,000
34,384,000,000
25,332,000,000
31,918,000,000
27,620,000,000
28,063,000,000
24,254,000,000
24,737,000,000
16,316,000,000
18,032,000,000
16,795,000,000
17,919,000,000
13,113,000,000
15,112,000,000
14,917,000,000
15,938,000,000
12,002,000,000
12,691,000,000
13,416,000,000
15,021,000,000
11,079,000,000
12,107,000,000
12,145,000,000
13,222,000,000
10,370,000,000
11,138,000,000
12,498,000,000
13,609,000,000
10,571,000,000
12,462,000,000
12,643,000,000
13,004,000,000
10,942,000,000
12,301,000,000
12,602,000,000
11,953,000,000
10,314,000,000
10,136,000,000
10,548,000,000
12,485,000,000
8,352,000,000
8,454,000,000
8,989,000,000
8,301,000,000
7,790,000,000
8,299,000,000
8,681,000,000
7,769,000,000
7,452,000,000
7,359,000,000
6,943,000,000
6,057,000,000
5,811,000,000
5,456,000,000
5,368,000,000
5,290,000,000
4,705,000,000
4,656,000,000
4,608,000,000
4,317,000,000
2,992,000,000
3,607,000,000
3,884,000,000
3,505,000,000
3,109,391,000
3,506,000,000
3,251,160,000
2,868,000,000
1,363,921,800
2,857,036,000
4,395,179,000
2,371,917,000
2,406,844,000
2,535,146,000
2,492,655,000
1,729,878,000
1,676,119,000
2,413,006,000
2,338,691,000
1,787,413,000
2,121,373,000
1,831,223,000
1,907,262,000
1,595,085,000
0
0
0
1,644,932,000
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.